1. null
   Siyuan Liang et al, 2017 CrossRef
2. Mammalian Sulfur Amino Acid Metabolism: a Nexus between Redox Regulation, Nutrition, Epigenetics and Detoxification
   María Angeles Pajares et al, 2017, Antioxidants & Redox Signaling CrossRef
3. Combined seven miRNAs for early hepatocellular carcinoma detection with chronic low-dose exposure to microcystin-LR in mice
   Lizhi Xu et al, 2018, Science of The Total Environment CrossRef
4. Prognostic role of EZH2 in gliomas: a meta-analysis
   Jung-Soo Pyo et al, 2018, The International Journal of Biological Markers CrossRef
5. Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
   Nasrin Rastgoo et al, 2018, Leukemia CrossRef
6. High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors
   Ning Zhang et al, 2018, Sci Rep CrossRef
7. Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek’s Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens
   Sabari Nath Neerukonda et al, 2019, Genes CrossRef
8. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis
   Libin Zhang et al, 2019 CrossRef
9. Novel Genes Associated with the Development of Carotid Paragangliomas
   A. V. Snezhkina et al, 2019, Mol Biol CrossRef
10. ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway
    Nuozhou Wang et al, 2019, Cancer Letters CrossRef
11. The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
    Simona Pellecchia et al, 2020, Cancers CrossRef
12. Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
    Lisa Linck-Paulus et al, 2020, Cells CrossRef
13. The protective effects of microRNA-26a in steroid-induced osteonecrosis of the femoral head by repressing EZH2
    Gang Li et al, 2020, Cell Cycle CrossRef
14. EZH2 overexpression is associated with poor prognosis in patients with glioma
    Yanyang Zhang et al, 2017, Oncotarget CrossRef
15. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
    Anthos Christofides et al, 2016, Oncotarget CrossRef
16. EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c
    Leibo Xu et al, 2020, Oncogenesis CrossRef
17. A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis
    Kun Liao et al, 2020, Cancer Res CrossRef
18. EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
    Ting Liu et al, 2021, Front. Oncol. CrossRef
19. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
    Kurt Sartorius et al, 2021, Front. Immunol. CrossRef
20. Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis.
    Hui-Hwa Tseng et al, 2021, Mol Ther Oncolytics CrossRef
21. Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer
    Yang Yi et al, 2022, Oncogene CrossRef
22. Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
    Peng Huang et al, 2022, Front. Cell Dev. Biol. CrossRef
23. Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas
    Marco De Martino et al, 2022, Cancers CrossRef
24. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
    Bing Bai et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
25. lncRNAMalat1and miR-26 cooperate in the regulation of neuronal progenitor cell proliferation and differentiation
    Nina Was et al, 2023, RNA CrossRef
26. EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Bohan Wang et al, 2023, Exp Hematol Oncol CrossRef
27. Systems biology investigation of epithelial-mesenchymal transition in hepatocellular carcinoma pathogenesis
    Fatemeh karimpour et al, 2023, Informatics in Medicine Unlocked CrossRef
28. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications
    Joanna Szczepanek et al, 2023, Biomolecules CrossRef
29. Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis
    Nicolas Bellini et al, 2024, Viruses CrossRef